Citadel Advisors’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-165,800
Closed -$21.9M 10307
2018
Q4
$21.9M Sell
165,800
-416,300
-72% -$53.3M 0.01% 1161
2018
Q3
$77.8M Sell
582,100
-43,600
-7% -$6.53M 0.03% 525
2018
Q2
$99.6M Buy
625,700
+597,500
+2,119% +$88.6M 0.05% 370
2018
Q1
$4.03M Sell
28,200
-67,800
-71% -$9.27M ﹤0.01% 2705
2017
Q4
$12.8M Buy
96,000
+21,000
+28% +$2.68M 0.01% 1503
2017
Q3
$9.33M Buy
75,000
+19,800
+36% +$2.73M 0.01% 1665
2017
Q2
$7.76M Buy
55,200
+18,800
+52% +$2.35M 0.01% 1673
2017
Q1
$4.1M Sell
36,400
-20,700
-36% -$2.41M ﹤0.01% 2250
2016
Q4
$6M Buy
57,100
+22,200
+64% +$2.39M 0.01% 1801
2016
Q3
$4.4M Sell
34,900
-2,900
-8% -$369K ﹤0.01% 2106
2016
Q2
$5.22M Sell
37,800
-18,100
-32% -$2.39M 0.01% 1788
2016
Q1
$7.76M Sell
55,900
-12,200
-18% -$1.67M 0.01% 1392
2015
Q4
$11M Sell
68,100
-20,800
-23% -$3.21M 0.01% 1209
2015
Q3
$11.9M Buy
88,900
+33,100
+59% +$4.32M 0.01% 1232
2015
Q2
$6.39M Sell
55,800
-19,200
-26% -$2.3M 0.01% 1837
2015
Q1
$8.95M Sell
75,000
-38,500
-34% -$5.13M 0.01% 1551
2014
Q4
$16.5M Buy
113,500
+17,100
+18% +$2.15M 0.02% 1070
2014
Q3
$12.7M Sell
96,400
-2,600
-3% -$342K 0.01% 1206
2014
Q2
$12.4M Buy
99,000
+48,900
+98% +$6.32M 0.01% 1108
2014
Q1
$8.03M Sell
50,100
-76,300
-60% -$12.6M 0.01% 1417
2013
Q4
$17M Buy
126,400
+62,100
+97% +$7.98M 0.02% 896
2013
Q3
$6.98M Buy
64,300
+23,000
+56% +$2.49M 0.01% 1334
2013
Q2
$3.5M Buy
+41,300
New +$3.7M 0.01% 1909

Citadel Advisors's ATHN Position: Q1 2019 in Review

Citadel Advisors sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 794,608 shares — an estimated $105M sold.

Citadel Advisors first reported a position in ATHN in Q2 2013 and held it in 22 quarters. The position peaked at $105M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Citadel Advisors reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citadel Advisors sold 794,608 Athenahealth, Inc. shares in Q1 2019, an estimated $105M.
  • Citadel Advisors first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 22 quarters.
  • Citadel Advisors's Athenahealth, Inc. position peaked at $105M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.